REGISTER NOW
SUBMIT ABSTRACT
7th World Cancer Congress - 2022 | Bangalore 10 Edition of World Cancer Congress - 2026 | London 7th World Cancer Congress - 2022 | Bangalore
THEME: "PRACTICAL APPROACH IN TREATING DIABETES AND ENDOCRINAL DISORDER"
7th World Cancer Congress - 2022 | Bangalore

🌍 2nd World Congress on Diabetes and Endocrinology – 2026

📅 23–24 October 2026 | 📍 Dubai, United Arab Emirates

🎯 Theme: “Practical Approach in Treating Diabetes and Endocrinal Disorder”


We are pleased to welcome you to the 2nd World Congress on Diabetes and Endocrinology – 2026, scheduled to take place from 23rd to 24th October 2026 in Dubai, UAE.

This global congress aims to unite leading experts, clinicians, researchers, and healthcare professionals working in the fields of diabetes and endocrinology. With the central theme of “Practical Approach in Treating Diabetes and Endocrinal Disorder,” the congress will highlight evidence-based practices and recent advances in clinical care.

The scientific program will feature keynote lectures, plenary sessions, and expert panel discussions focusing on current trends in diabetes treatment, advances in endocrinal diagnostics and therapeutics, the role of technology in disease management, and emerging research in metabolic health.

We encourage clinicians, academic researchers, industry leaders, and allied healthcare professionals to join us in Dubai for this important international event. The congress will provide ample opportunity for knowledge sharing, interdisciplinary networking, and professional growth.

We look forward to welcoming you to Dubai in October 2026 for two days of enriching dialogue and scientific advancement.

Sincerely,
Organizing Committee
2nd World Congress on Diabetes and Endocrinology – 2026


🔬 Scientific Tracks

The Scientific Committee of the 2nd World Congress on Diabetes and Endocrinology – 2026 is proud to present a comprehensive array of session topics designed to reflect current clinical challenges, translational research, and future innovations in the field.

  • 💉 Advances in Type 1 and Type 2 Diabetes Management – Modern therapeutic strategies, combination treatments, and individualized glycemic targets.
  • 📱 Innovations in Insulin Delivery and Glucose Monitoring – Smart insulin devices, continuous glucose monitors (CGM), and closed-loop systems.
  • 👶 Gestational and Pediatric Diabetes – Diagnosis and management in children, adolescents, and during pregnancy.
  • 🧠 Endocrine Disorders and Hormonal Therapies – Updates on pituitary, adrenal, thyroid, and reproductive endocrine dysfunction.
  • ⚖️ Obesity, Metabolic Syndrome, and Lipid Disorders – Medical, nutritional, and surgical approaches to weight and lipid regulation.
  • ❤️ Diabetic Complications and Comorbidities – Prevention and treatment of nephropathy, neuropathy, retinopathy, and cardiovascular risk.
  • 🧬 Endocrine Tumors and Oncology – Advances in diagnosis and targeted therapies for endocrine-related malignancies.
  • 🦋 Thyroid Dysfunction and Autoimmune Endocrinopathies – Clinical updates on hypothyroidism, hyperthyroidism, Hashimoto’s and Graves’ disease.
  • 🦴 Bone Health and Calcium Disorders – Osteoporosis, parathyroid conditions, and vitamin D-related bone metabolism.
  • 🤖 Artificial Intelligence and Digital Health in Endocrinology – Machine learning, digital therapeutics, and tele-endocrinology in clinical practice.
  • 🔬 Clinical Trials and Translational Research – Bridging the gap from bench to bedside with impactful clinical research.


📝 Submit Abstract

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days.

Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.

Abstract Guidelines:

  • The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
  • The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
  • Do not use bold type or underline formatting. Italic type is acceptable.
  • Text may be in multiple paragraphs.
  • Any references should be noted as citations within the text and not as footnotes at the end.
Important Dates
1st Phase Abstract Submission Deadline: 15th November, 2025
Early Bird Registration Closes: 21st September, 2025
Click Here to Submit Abstract
Click Here to Download Information Brochure


7th World Congress on Drug Discovery and Development - 2022 | Bangalore

CONTACT US AT

Conference Secretariat
UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US


INDIA
ARJYOPA HEALTHCARE
H. No -02, Floor No 1&2, DumDum
Kolkata - 700078, West Bengal, India

WRITE TO US


10th World Cancer Congress - 2026 | London
ORGANISED BY



GLIMPSE OF PAST SPEAKERS




7th World Cancer Congress - 2022 | Bangalore




MAIL US AT
Sponsorship/Exhibitions: [email protected]
General Enquiries: [email protected]


Copyright@2014-2025, Arjyopa Healthcare. All Right Reserved